Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed”

10,396 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 10,396 results

Testing effectiveness (Phase 2)UnknownNCT02825836
What this trial is testing

Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects

Who this might be right for
Relapsed/Refractory B Cell MalignanciesMantle Cell Lymphoma and Diffuse Large B Cell LymphomaChronic Lymphocytic Leukemia+2 more
Telios Pharma, Inc. 130
Testing effectiveness (Phase 2)Ended earlyNCT03769532
What this trial is testing

MRD-guided Treatment in NPM1mut AML Patients

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 26
Early research (Phase 1)Study completedNCT02482532
What this trial is testing

Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma

Who this might be right for
Melanoma
Gary Doolittle 7
Early research (Phase 1)Ended earlyNCT03420963
What this trial is testing

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Cutaneous MelanomaRecurrent Lip and Oral Cavity CarcinomaRecurrent Malignant Endocrine Neoplasm+25 more
M.D. Anderson Cancer Center 12
Large-scale testing (Phase 3)Study completedNCT00005863
What this trial is testing

Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Medical Research Council
Not applicableWithdrawnNCT04503538
What this trial is testing

Telemedicine for Early Detection of Cytokine Release Syndrome and Neurotoxicity

Who this might be right for
Large B-cell LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal Large B Cell Lymphoma+2 more
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Active Not RecruitingNCT06869785
What this trial is testing

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals 196
Large-scale testing (Phase 3)Ended earlyNCT00072215
What this trial is testing

Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorTesticular Germ Cell Tumor
Alliance for Clinical Trials in Oncology 1
Early research (Phase 1)Looking for participantsNCT07315087
What this trial is testing

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

Who this might be right for
SLE - Systemic Lupus ErythematosusSSc-Systemic SclerosisIIM- Idiopathic Inflammatory Myopathies+3 more
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Looking for participantsNCT05145816
What this trial is testing

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

Who this might be right for
AL AmyloidosisAmyloidosis
University of Texas Southwestern Medical Center 37
Testing effectiveness (Phase 2)WithdrawnNCT02628704
What this trial is testing

Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc
Testing effectiveness (Phase 2)Study completedNCT01274533
What this trial is testing

Lenalidomide in HTLV-1 Adult T-Cell Leukemia

Who this might be right for
Adult T Cell Leukemia/Lymphoma
Columbia University 4
Large-scale testing (Phase 3)Looking for participantsNCT06776952
What this trial is testing

A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Relapsed/Refractory Peripheral T Cell Lymphoma
Evopoint Biosciences Inc. 120
Large-scale testing (Phase 3)Looking for participantsNCT07579234
What this trial is testing

A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma (RRMM)
Shandong New Time Pharmaceutical Co., LTD 261
Very early researchNot Yet RecruitingNCT06702098
What this trial is testing

Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Guangzhou Ruixin Biotechnological Co., LTD 10
Large-scale testing (Phase 3)Ended earlyNCT03870763
What this trial is testing

Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 11
Early research (Phase 1)Temporarily pausedNCT03710421
What this trial is testing

CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
City of Hope Medical Center 30
Not applicableStudy completedNCT04691648
What this trial is testing

Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation

Who this might be right for
Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
Astellas Pharma Korea, Inc. 33
Testing effectiveness (Phase 2)Study completedNCT04593758
What this trial is testing

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

Who this might be right for
Sarcoma, Clear Cell
Cornerstone Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT01030900
What this trial is testing

Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas

Who this might be right for
Hodgkin LymphomaDiffuse Large B-Cell Lymphoma
National Cancer Institute (NCI) 50
Load More Results